Huadong Medicine with AI leader Insilico improve drug innovation
Aitechpark09 Sep, 2021Technology
Huadong Medicine (SZ.000963) and Insilico Medicine (?Insilico?), an end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the companies have entered into a co-development partnership to accelerate the discovery of breakthrough small-molecule therapeutics by leveraging an innovative approach to oncology.
Related Bookmarks
- EagleAi Platform for business is now available in AWS Marketplace
- Snapsheet Joins NVIDIA to Accelerate the Development of AI Models
- office.com/setup | Enter your Office product key | www.office.com/setup
- Brightflag Awarded U.S. Patent for AI in Legal Operations
- Software Development Company in Lahore � techbridgeconsultancy
- Top 10 Unbelievable Benefits of React native for Cross Platform App Development
- iPhone 13�s satellite connectivity may not be all we imagined
- Awesome Sound System Rental in Dubai at Affordable Price
- Top 5 Required Features to Build Great iOS Apps
- A Comprehensive Guide On Developing A Robust School Bus Management Software
Recent Profiles
Bet88mit
Moharani123
Mv88
Jamaica Ocean View Villa
Modern Furnace And Air Conditioning, Llc
Burke Romero
Kofod Mcdonald
K88club
Crop The Tomato
The Dwoskin Family Foundation